Maryaline Catillon

En 20 ans, la France est passée de la 5ème à la 9ème place mondiale en recherche biomédicale. Comment restaurer la compétitivité de la recherche française? Diagnostic et réponses dans mon article. dg-chru.fr/revue-deconomi… #recherche #sante #reforme #Presidentielle2022

Manager Maryaline Catillon presented on the role of research and real-world data in hospital innovation and patient care at the AIA Life Designers conference in Lyon. analysisgroup.com/news-and-event…

Season's greetings from Analysis Group! We are a firm of many different people, backgrounds, and cultures. Our people speak more than 45 languages and have just as many ways to wish you a happy holiday season.

An Analysis Group team led by Mihran Yenikomshian, Lynn Huynh, Enrico Zanardo, and Rui Song studied the real-world effectiveness of a novel therapy on patients' need for blood transfusions. analysisgroup.com/news-and-event…

Today we announce a leadership transition. Pierre Cremieux is now Analysis Group’s CEO. Martha Samuelson, who was previously CEO and Chairman, will continue as Chairman and maintain her active consulting practice. analysisgroup.com/news-and-event…

I asked my Ukrainian friends how to help. Everybody cannot go fight for democracy in Ukraine. But everybody can help them win. bank.gov.ua/en/news/all/na…

Applications to our first-ever Rise@AG Externship are open! Rise@AG is a week-long, case-shadowing program designed to introduce academically curious sophomores (class of 2024) from underrepresented backgrounds to the world of economic consulting. analystcareers-analysisgroup.icims.com/jobs/1831/2022…

1 / 7 Excited to announce new book with practical advice aimed at helping people think more analytically. Based on the wisdom of legendary @Harvard Professor Richard Zeckhauser #ThinkingAnalytically. 🧵 📘Paperback: amazon.com/dp/173534088X 💻Ebook: amazon.com/dp/B098GLJS51

Beautifully written article (unfortunately so true) about French bureaucracy. France needs more data driven policies and less bureaucracy. via @NYTimes nytimes.com/2021/04/26/wor…

Hydroxychloroquine & other drugs proposed for #COVID-19 treatments have had shortages. We find news coverage contributes to shortages due to 1) hoarding by individuals & 2) stockpiling by institutions. medrxiv.org/cgi/content/sh… @maiamajumder @MaryalineC @smanzi2 @Bos_CHIP

Britain's failure to learn the hard lessons of its first Covid surge is a disaster | Coronavirus outbreak | The Guardian theguardian.com/commentisfree/…

Six feet may not be enough to protect against coronavirus, experts warn …tonpost-com.ezp-prod1.hul.harvard.edu/health/2020/08…

Applications for the #COVID19 Dispersed Volunteer Research Network [covid19dvrn.org] are now live! With volunteers across disciplines, we've served as a virtual lab for 100+ researchers since March 2020. Retweet to get the word out & apply today: airtable.com/shr7oLm0Ouxm5i…

En #France, on prévoit déjà de rouvrir les écoles à partir du 11 mai...

En #France, face au #COVID19 deux mesures d’urgence sont nécessaires: plus de recherche (de qualité) en temps réel sur les bases de données existantes, et moins de bureaucratie. ⁦@DabWilliam⁩ @lemondefr ⁦@EmmanuelMacron⁩ ⁦@olivierveran⁩ lemonde.fr/planete/articl…

En #psychiatrie comme dans les #Ehpads, il n'y a pas assez de #masques ni de #tests pour les #soignants et les patients. Les #coronadoks connaissent les gestes barrière mais redoutent le pire... #COVID19 #cartoons #humour

« De la folie dans la folie, #COVID19 en #psychiatrie » alerte sur la situation des #soignants et des patients. Sans mesures urgentes et fortes, une situation similaire à celle des #EHPAD est à redouter très prochainement. #masques #tests #TestonsChezNous facebook.com/52017959136694…

@EmmanuelMacron @olivierveran @gouvernementFR Pourquoi? Toutes les resources disponibles devraient être utilisées pour augmenter la capacité en tests le plus rapidement possible. #TestonsChezNous francebleu.fr/infos/sante-sc…

@EmmanuelMacron @olivierveran @gouvernementFR Il n’est pas éthique avec les données scientifiques disponibles d’exiger des essais cliniques prolongés, ni de réserver les traitements prometteurs aux malades déjà en état grave. Ces délais tuent. Faites confiance à ceux qui savent.